WM-586
WM-586 is a covalent WDR5 inhibitor. WM-586 specifically decreases WDR5 and MYC interaction with an IC50 of 101 nM. WM-586 is used in research on a variety of cancers including neuroblastoma, breast cancer, bladder cancer and colorectal cancer[1].
Product Specifications
CAS Number
2894832-05-2
UNSPSC
12352005
Target
WDR5
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/wm-586.html
Purity
98.74
Solubility
10 mM in DMSO
Smiles
FC1=C(C[C@H](CCCC)C(NC2=NN=NN2)=O)C(F)=CC(C3=CC(S(F)(=O)=O)=CC=C3)=C1
Molecular Formula
C20H20F3N5O3S
Molecular Weight
467.46
References & Citations
[1]Ding J, et al. Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction. ACS Chem Biol. 2023 Jan 20;18 (1) :34-40.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-A603090-500MG 500 mg
4-Amino-5-carboxy-2-ethylmercaptopyrimidine
Sign In for Pricing
View Details 
E-AB-V1091-01 20 µL
Anti-Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350/EBV GP350 Polyclonal Antibody
Sign In for Pricing
View Details E-AB-V1091-02 100 µL
Anti-Epstein-Barr virus (Herpesvirus 4) EBV Glycoprotein gp350/EBV GP350 Polyclonal Antibody
Sign In for Pricing
View Details 
BNC403786-100 1x 100 µL
AKT1 (Prognostic Marker for Neuroendocrine Tumors) (rAKT1/2491), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details